Stock SABS SAB BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Delayed Nasdaq
Other stock markets
 01:17:09 2024-06-12 pm EDT 		5-day change 1st Jan Change
3.355 USD -1.03% Intraday chart for SAB Biotherapeutics, Inc. +22.85% -51.20%
Jun. 07 Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target MT
May. 30 SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Revisions SAB Biotherapeutics, Inc.